Martin Irvine: Good evening. I'm Dr. Martin Irvine, Editorial Director of Medscape, and I would like to welcome you to our
live Web conference on "Individualizing Hormone Therapy for the Surgically Menopausal Woman." This is a CME activity made
possible by an independent educational grant from Novagyne Pharmaceuticals.
Before we begin, let me take a few moments to go over the format of tonight's program. We will begin with a presentation from
Dr. Philip Sarrel, who will discuss the role of estrogen therapy in surgical menopause. This will be followed by a presentation
from Dr. Lila Nachtigall, who will focus on individualizing estrogen therapy for the surgically menopausal woman.
Each presentation will last around 15 to 20 minutes, and at some point during each presentation there will be 2 simple polling
questions for you, the audience, to answer.
At the completion of each presentation, there will be a brief question-and-answer session, so the listeners are encouraged
to ubmit questions via the box in the bottom left of your screen. You may submit a question at any time during the presentation.
At the end of the program, a popup will appear with a link to the posttest, where you can answer questions and obtain CME
credit.
Now I would like to introduce our first presenter, Dr. Philip Sarrel, Emeritus Professor of Obstetrics, Gynecology, and Psychiatry
at Yale University in New Haven, Connecticut. Dr. Sarrel will discuss the role of estrogen therapy in surgical menopause.
Dr. Sarrel, good evening.
